澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ADALTA LTD

0.004

-0.001-20.00%

成交量：100.41萬

成交額：5,019.00

市值：1,019.87萬

市盈率：-0.06

高：0.005

開：0.005

低：0.004

收：0.005

52周最高：0.160

52周最低：0.003

股本：25.50億

流通股本：7,579.14萬

量比：1.16

換手率：1.32%

股息：- -

股息率：- -

每股收益(TTM):-0.069

每股收益(LYR):-0.069

淨資產收益率：-628.72%

總資產收益率：-72.30%

市淨率：-17.05

市盈率(LYR):-0.06

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Adalta與上海細胞治療集團達成協議共同開發Bzds1901大中華區以外全球市場

Adalta撤回2025年股東大會上關於股份合併的第六項決議

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/1AD.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"1AD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AD.AU\",,,,,undefined,":{"symbol":"1AD.AU","market":"AU","secType":"STK","nameCN":"ADALTA LTD","latestPrice":0.004,"timestamp":1770700320000,"preClose":0.005,"halted":0,"volume":1004144,"delay":0,"changeRate":-0.2,"nameEN":"ADALTA LTD","floatShares":75791359,"shares":2549669000,"eps":-0.068999,"marketStatus":"已收盤","change":-0.001,"latestTime":"02-10 16:12:00 AEDT","open":0.005,"high":0.005,"low":0.004,"amount":5019,"amplitude":0.2,"askPrice":0.005,"askSize":11840114,"bidPrice":0.004,"bidSize":26113037,"shortable":3,"etf":0,"ttmEps":-0.068999,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.005,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":1.162778,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AD.AU\",,,,,undefined,":{"symbol":"1AD.AU","floatShares":75791359,"roa":"-72.30%","roe":"-628.72%","lyrEps":-0.068939,"volumeRatio":1.162778,"shares":2549669000,"dividePrice":0,"high":0.005,"amplitude":0.2,"preClose":0.005,"low":0.004,"week52Low":0.003,"pbRate":"-17.05","psRate":"15.06","week52High":0.16,"institutionHeld":0,"latestPrice":0.004,"committee":0.376067,"eps":-0.068999,"divideRate":0,"volume":1004144,"delay":0,"ttmEps":-0.068999,"open":0.005,"prevYearClose":0.003,"prevWeekClose":0.004,"prevMonthClose":0.005,"prevQuarterClose":0.003,"fiveDayClose":0.004,"twentyDayClose":0.006,"sixtyDayClose":0.04,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/1AD.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-12-09","symbol":"1AD.AU","defaultRemindTime":1765234800000,"type":"split","dateTimestamp":1765198800000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"AU","date":"2021-12-17","symbol":"1AD.AU","defaultRemindTime":1639695600000,"type":"split","dateTimestamp":1639659600000,"forFactor":990277,"toFactor":1000000,"ratio":0.990277},{"market":"AU","date":"2020-08-13","symbol":"1AD.AU","defaultRemindTime":1597276800000,"type":"split","dateTimestamp":1597240800000,"forFactor":981818,"toFactor":1000000,"ratio":0.981818}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"1AD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"1AD.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1175535273","title":"Adalta與上海細胞治療集團達成協議 共同開發Bzds1901大中華區以外全球市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1175535273","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175535273?lang=zh_tw&edition=fundamental","pubTime":"2026-01-02 06:21","pubTimestamp":1767306079,"startTime":"0","endTime":"0","summary":"Adalta有限公司宣布与上海细胞治疗集团签署合作协议，双方将共同开发创新药物Bzds1901。根据协议条款，Adalta将获得该药物在大中华区（包括中国大陆、香港、澳门和台湾）以外所有全球市场的独家开发和商业化权利。此次合作标志着Adalta在拓展全球细胞治疗市场方面迈出重要一步，也为Bzds1901的国际化布局奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AD.AU"],"gpt_icon":0},{"id":"1160290721","title":"Adalta撤回2025年股東大會上關於股份合併的第六項決議","url":"https://stock-news.laohu8.com/highlight/detail?id=1160290721","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160290721?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 01:04","pubTimestamp":1763571893,"startTime":"0","endTime":"0","summary":"11月7日——Adalta Ltd宣布：*关于提议的股份合并的第六项决议已从2025年股东大会中撤回*更多公司动态：1AD.AX*","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["1AD.AU","BK7067"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/1AD.AU\",params:#limit:6,delay:true,,,undefined,":[]}}